ROIV position history
The shares of Roivant Sciences (ROIV) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q2: 2,355,000 shares, $24M, 0.13% of portfolio, New
- 2023 Q3: 3,853,400 shares, $45M, 0.23% of portfolio, Add +63.6%
- 2023 Q4: 7,336,000 shares, $82M, 0.41% of portfolio, Add +90.4%
- 2024 Q1: 1,797,200 shares, $19M, 0.09% of portfolio, Reduce −75.5%
- 2024 Q2: 673,000 shares, $7.1M, 0.03% of portfolio, Reduce −62.6%
- 2024 Q3: 37,000 shares, $427K, <0.01% of portfolio, Reduce −94.5%
- 2024 Q4: 37,000 shares, $438K, <0.01% of portfolio
- 2025 Q1: 37,000 shares, $373K, <0.01% of portfolio
- 2025 Q2: 37,000 shares, $417K, <0.01% of portfolio
- 2025 Q3: 74,000 shares, $1.1M, <0.01% of portfolio, Add +100.0%
- 2025 Q4: 37,000 shares, $803K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 9,675,000 shares, $268M, 1.5% of portfolio, Add +26048.6%
- 2026 Q2: 14,309,000 shares, $506M, 2.3% of portfolio, Add +47.9%
- 2026 Q3: 21,745,533 shares, $795M, 3.4% of portfolio, Add +52.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|